Aatmaj Healthcare Limited

Aatmaj Healthcare Limited

NNSE:AATMAJ
26.75
INR
+0.75
(+2.88%)
0.32EPS
58.13P/E
414.71MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
1.93
7.64
9.65
12.02
6.96
8.56
10.76
Basic EPS, GAAP
-0.12
1.82
2.18
2.61
0.39
0.28
0.32
Free Cash Flow per Basic Share
-0.32
2.45
-0.38
1.92
-7
1.46
3.13
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.41
1.41
3.59
6.27
21.89
- -
22.49
Tangible Book Value per Share
-0.43
1.4
3.56
6.26
19.39
- -
15.02
Basic Weighted Avg Shares
23
23
23
23
23
23
23
Sales/Revenue/Turnover
44
173
218
272
157
195
243
Operating Margin (%)
7.21
28.37
32.5
34.64
11.09
3.26
5.71
Depreciation Expense
4
4
4
7
8
9
10
Net Income, GAAP
-3
41
49
59
9
6
7
Effective Tax Rate (%)
- -
7.52
28.12
28.61
34.4
40.3
26.41
Profit Margin (%)
-6.2
23.88
22.56
21.74
5.6
3.27
2.93
Working Capital
-19
-14
-17
55
334
- -
306
LT Debt
67
33
7
18
12
- -
88
Total Equity
-9
32
81
142
495
- -
508
Return on Invested Capital (%)
- -
58.99
48.97
33.33
2.83
- -
- -
Return on Capital (%)
- -
57.75
48.1
33.02
4.07
- -
- -
Return on Common Equity (%)
- -
- -
87.11
53
2.77
- -
- -

Capital Structure

INR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

INR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
-239.54%
111.64%
Net Income, GAAP
- -
-12.3%
11.61%
Sales/Revenue/Turnover
- -
11.49%
24.49%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
157
2025
- -
- -
- -
- -
195
2026
- -
- -
- -
- -
243

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.39
2025
- -
- -
- -
- -
0.28
2026
- -
- -
- -
- -
0.32

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Tushar Karshanbhai Suvagiya
Full Time Employees
300
Sector
Health services
Industry
Hospital/Nursing management
Address
Near Sun City, Vasna Bhayli Road Vadodara GU India 391410
IPO Date
Jun 30, 2023
Business
Aatmaj Healthcare Ltd. operates multidisciplinary private hospitals and clinics, providing comprehensive inpatient and outpatient healthcare services across multi-specialty and super-specialty segments. The company offers a wide range of medical services including cardiology (invasive), neurology, neurosurgery, nephrology, anesthesiology, orthopedics, neonatology, dermatology, radiology, general and laparoscopic surgery, critical care medicine, internal medicine, emergency care, ear-nose-throat, gynecology, pediatrics, joint replacement, ophthalmology, urology, cosmetic surgery, neonatal intensive care, advanced trauma care, 24-hour ambulance services, echo cardiology, TMT, and comprehensive health checkups; its facilities feature advanced infrastructure such as cardiology cath labs, tertiary care ICUs, NICUs, modular operation theaters, and diagnostic equipment including CT scans. Targeting patients, corporate employees, and institutions in the healthcare sector, the company primarily serves communities in Gujarat, India, through its network of six hospitals under brands including Jupiter Hospital (tertiary care), JTP Hospitals-Muval and JTP Hospitals-Padra (secondary care), with an aggregate bed capacity of 330 beds extendable to 430 beds. Founded in 2014 and headquartered at Jupiter Hospital, Opp. ICAI Bhavan, Sun Pharma Atladra Road, Vadodara, Gujarat 390012, India, the company converted from a private limited entity (incorporated March 10, 2014) to a public limited company in December 2022 and listed on the NSE SME Emerge platform in July 2023. In recent developments, Aatmaj Healthcare expanded its bed capacity from 130 to 330 beds (extendable to 430) via IPO proceeds and strategic acquisitions of well-run single-doctor or multi-specialty hospitals owned by physicians aged 50+, often through low-capex lease and royalty models rather than outright purchases; this hospital chain growth initiative commenced approximately 1.5 years pre-IPO and continued into FY24. The company is pursuing further expansions including two IVF centers (allocated Rs. 4-5 crore), additional bed additions to reach 430, and long-term plans for oncology radiation units (Rs. 16 crore each), while supporting government initiatives like PMJAY for affordable care; it maintains NABH accreditation and employs 30 consultant doctors plus on-call specialists.